title: Bezafibrate for an inborn mitochondrial beta-oxidation defect.
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Bonnefont
authors.forename: Jean
authors.initials: J
authors.lastname: Bastin
authors.forename: Anthony
authors.initials: A
authors.lastname: Behin
authors.forename: Fatima
authors.initials: F
authors.lastname: Djouadi
mesh_terms: D000328:Adult; D001629:Bezafibrate / Q000627:therapeutic use*; D002334:Carnitine O-Palmitoyltransferase / Q000172:deficiency* / Q000378:metabolism; D005808:Genes, Recessive; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008052:Lipid Metabolism, Inborn Errors / Q000188:drug therapy* / Q000378:metabolism; D028361:Mitochondrial Diseases / Q000188:drug therapy* / Q000378:metabolism; D010084:Oxidation-Reduction; D010172:Palmitoylcarnitine / Q000378:metabolism; D010865:Pilot Projects; D011788:Quality of Life; D012333:RNA, Messenger / Q000378:metabolism; D012206:Rhabdomyolysis / Q000517:prevention & control; D018709:Statistics, Nonparametric
chemical_list: D000960:Hypolipidemic Agents; D012333:RNA, Messenger; D010172:Palmitoylcarnitine; D002334:Carnitine O-Palmitoyltransferase; D001629:Bezafibrate